← Back to News
Trust this SourceView Full Calendar
Portugal Outpatient Medicine Spend Rises 7.9%, Led by Diabetes Drugs
J
October 29, 2026
Big data analysis
Portugal outpatient medicine spend rose €98.1 million (7.9%) in January to August 2026, to €1,338.5 million, according to INFARMED, Portugal’s medicines regulator, in its monitoring report for August 2026. Patient payments rose 2.4% over the same period. Antidiabetics accounted for 32.3% of the increase, the largest contribution of any therapeutic class.
The report compares January to August 2026 with the same months of 2025. Its figures cover medicines dispensed in outpatient care.
Loading…
Let Google know we are your trusted source.
Add our editorial as a preferred source in your search results.
Value Science Weekly
The week in health technology assessment, market access and health economics — what moved, and what it means.